Rager, A <br/><br/>
Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.  [electronic resource] 

 -  Bone marrow transplantation  Mar 2011 
 - 430-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2010.117  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Daclizumab<br/>Drug Resistance<br/>Female<br/>Graft vs Host Disease--drug therapy<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Retrospective Studies<br/>Steroids--pharmacology<br/>Survival Analysis<br/>Treatment Outcome